首页> 外文OA文献 >Observer Variation in Interpreting F-18-FDG PET/CT Findings for Lymphoma Staging
【2h】

Observer Variation in Interpreting F-18-FDG PET/CT Findings for Lymphoma Staging

机译:观察F-18-FDG PET / CT淋巴瘤分期结果的观察者差异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many studies demonstrate a high accuracy for PET in staging lymphoma, but few assess observer variation. This study quantified agreement for staging lymphoma with PET/CT. Methods: The PET/CT images of 100 patients with lymphoma who had been referred for staging were reviewed by 3 experienced observers, with 2 observers reviewing each series a second time. Ann Arbor stage and individual nodal and extranodal regions were assessed. Weighted kappa (kappa(w)) and intraclass correlation coefficient were used to compare ratings. Results: Intra- and interobserver agreement was high for Ann Arbor stage (kappa(w) - 0.79-0.91), number of nodal regions involved (intraclass correlation coefficient, 0.83-0.93), and presence of extranodal disease (kappa = 0.74-0.86). High agreement was also observed for all nodal regions (kappa(w) > 0.60) except hilar (kappa(w) = 0.56-0.82) and infraclavicular (kappa(w) = 0.14-0.55). Lower agreement was observed for bowel involvement (kappa(w) = 0.37-0.71). Conclusion: Experienced observers had a high level of agreement using PET/CT for lymphoma staging, supporting its use as a robust noninvasive staging tool. Further research is needed to evaluate observer variability for restaging during and after chemotherapy.
机译:许多研究表明PET在分期淋巴瘤中具有很高的准确性,但很少评估观察者的差异。这项研究量化了PET / CT分期淋​​巴瘤的共识。方法:由3位经验丰富的观察者对100例已转诊分期的淋巴瘤患者的PET / CT图像进行了回顾,其中2位观察者第二次对每个系列进行了回顾。 Ann Arbor阶段以及单个节和节外区域进行了评估。加权kappa(kappa(w))和组内相关系数用于比较等级。结果:在安娜堡阶段(kappa(w)-0.79-0.91),涉及的淋巴结区域数量(类内相关系数,0.83-0.93)和存在结外疾病(kappa = 0.74-0.86)的观察者间和观察者间一致性高。 )。除肺门(kappa(w)= 0.56-0.82)和锁骨下(kappa(w)= 0.14-0.55)外,所有淋巴结区域(kappa(w)> 0.60)也观察到高度一致性。肠受累程度较低(kappa(w)= 0.37-0.71)。结论:经验丰富的观察者对PET / CT进行淋巴瘤分期有很高的共识,支持将其用作可靠的无创分期工具。需要进一步的研究来评估观察者在化疗期间和之后进行分期的变异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号